Clovis Medicaid spending for Pathology and Laboratory Procedures rises 2% in 2024

In 2024, Clovis Medicaid providers billed $2,216,056 for services in the Pathology and Laboratory Procedures category, based on data from the U.S. Department of Health and Human Services Medicaid Provider Spending database. That figure shows a 2% rise over 2023, when providers filed $2,173,529 in claims for the same service grouping.

Medicaid is a state-administered health insurance program funded jointly by federal and state governments. It serves low-income individuals, families, seniors, children, and people with disabilities, making it a key component of the U.S. health care system.

As taxpayer-funded payments support Medicaid, variations in local claims indicate how community public health funds are distributed.

The “Pathology and Laboratory Procedures” category comprises Medicaid-billed services organized by type of care, using uniform HCPCS and CPT coding systems. This analysis grouped billing codes into a single service category by shared prefixes and ranges, ensuring consistency and accuracy in historical rankings while preventing double-counting of services.

While Medicaid expenses grew in several service areas, Pathology and Laboratory Procedures placed seventh in Clovis for total Medicaid payments in 2024.

Statewide, Pathology and Laboratory Procedures ranked eighth in New Mexico by total Medicaid payments in 2024.

Between 2019 and 2024, Medicaid payments in Clovis linked to Pathology and Laboratory Procedures rose by $1,067,612, or 93%. Growth further accelerated in certain years, with prominent annual increases recorded during 2023 and 2021.

Though spending spanned different parts of Clovis, the majority of Medicaid payments related to this care category were concentrated in a small number of ZIP codes. In 2024, ZIP code 88101 accounted for the full $2,216,056 in Medicaid claims for Pathology and Laboratory Procedures. This top ZIP code represented 100% of such payments citywide that year.

Within this category, a small subset of billing codes accounted for the largest share of Medicaid payments.

For reference, the 2% rise in Clovis Medicaid spending for Pathology and Laboratory Procedures between 2024 and 2023 compares to a 12.4% change across all claim categories in the city for the same timeframe.

According to the Centers for Medicare & Medicaid Services, total federal and state Medicaid expenditures reached about $871.7 billion in fiscal year 2023, representing around 18% of total U.S. health spending, and up from $613.5 billion in 2019, prior to the COVID-19 pandemic.

This increase represents an approximate 40% rise over a span of several years, largely attributed to broadening program eligibility and greater patient use both during and after the pandemic.

Federal budget packages signed under the Trump administration have included proposals to cut federal Medicaid support and change the structure of the program. The “One Big Beautiful Bill Act,” enacted in 2025, is expected to reduce federal Medicaid funding by over $1 trillion in the upcoming decade and implements measures such as work requirements and increased cost-sharing that may reduce coverage and funding for certain beneficiaries. These policies could transfer more financial responsibility to states and are poised to constrain federal contributions as the Medicaid program continues serving millions of Americans.

Note: HCPCS codes are shown for context within the category. Category totals and rankings in this article are based on standardized service groupings rather than individual billing codes.

Information in this article was obtained from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The source data can be found here.